STARTUP SPOTLIGHT AT BIO-EUROPE
This exciting competition offers entrepreneurs an affordable opportunity to engage with top-tier investors and other important players in the biotech industry to take their business to the next level.
Deadline to apply: September 9, 2024
Presenting Details
Selected companies will have the opportunity to make a 6-minute pitch and participate in a live feedback session with a panel of judges of leading investors, pharma dealmakers, and biotech business key opinion leaders who will evaluate the pitches and select the winner onsite in Stockholm, Sweden.
Pitching Benefits
- Visibility: Generate interest among the global life science audience attending BIO-Europe.
- A complimentary registration to attend BIO-Europe and request one-to-one meetings, facilitated by partneringONE®, with investors and other attendees.
- Startup Spotlight Winner — Selected by judges: A complimentary registration to attend a future EBD event.
Pitching Criteria
Applications can be submitted by companies that meet the following eligibility criteria:
- Company created in the past three years, or innovation incubated within a company for a maximum of three years
- Developing new therapeutic solutions, technology and digital platforms
- Working in therapeutic areas that include: Cardiovascular, Cell & Gene, Oncology, Immunology, Neurology and Rare Diseases, Radiology, Digital Health
- Aggregate funding of €10 million or less
- Company with less than 25 employees
Fee Structure
Pitch fee: €195.00*
*Qualifying criteria must be met for this rate
If selected to present, you will receive additional steps to claim your complimentary BIO-Europe registration and submit payment to secure your presentation slot.
Startup Spotlight at BIO-Europe Sponsor
Hear from Bayer—Startup Spotlight Sponsor
2023 Startup Spotlight Presenters
Meet the finalists
Last Years Startup Spotlight Winner
Congratulations to the Startup Spotlight 2023 winner, PannTheraPi.
PannTheraPi is an innovative pharmaceutical company dedicated to the development of innovative drugs, aiming for better efficacy and tolerance than current ones for the treatment of brain and nervous diseases.
Thank you to Bayer for sponsoring the competition, and to all our other finalists and entries.